化合物MI-3 T2643
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
25 mg | 1271738-59-0 | ¥2,970.00 | 询底价 |
1 mg | 1271738-59-0 | ¥485.00 | 询底价 |
1 mL | 1271738-59-0 | ¥1,270.00 | 询底价 |
10 mg | 1271738-59-0 | ¥1,830.00 | 询底价 |
50 mg | 1271738-59-0 | ¥4,570.00 | 询底价 |
5 mg | 1271738-59-0 | ¥1,160.00 | 询底价 |
Product Introduction
Bioactivity
英文名: MI-3
描述: MI-3 (Menin-MLL Inhibitor)是一种有高亲和力的 menin-MLL 抑制剂,IC50值为 648 nM,Kd 值为 201 nM。
细胞实验: The MLL-AF9 and E2A-HLF transduced murine BMC are plated in 12-well plates at the concentration of 5×103 cells/mL with 1 mL methylcellulose medium M3234 containing 20% IMDM medium, 1% penicillin/streptomycin, IL-3 and 0.25% DMSO or compounds. 6 days later colonies are stained with 100 μL iodonitrotetrazolium chloride at final concentration of 1 mg/mL, incubated at 37°C for 30 min and counted. To replate for the 2nd round, colonies are counted at day 6 without staining and cells were washed out by 1×PBS buffer and resuspended in IMDM medium containing 15% FBS, 1% penicillin/streptomycin and IL-3. 5×103 cells are plated in 12-well plates with 1ml methylcellulose medium M3234 containing 20% IMDM medium, 1% penicillin/streptomycin, IL-3 and 0.25% DMSO or compounds. 6 days later colonies are stained and counted. (Only for Reference)
激酶实验: High Throughput Screening: FITC-MBM1 at 15 nM and menin at 150 nM in the FP buffer are mixed and incubated for 1h in the dark at room temperature. For point screening, the 0.2 μL of each compound (20 μM final concentration, 1% DMSO) is added to 20 μL of the aliquot of the protein-peptide mixture and incubated on 384-well plates in the dark at room temperature for 1h. In confirmation screening, the serial dilution plates with compounds in DMSO are prepared and used to titrate the menin-FITC-MBM1 complex. Change in fluorescence polarization is monitored at 525 nm after excitations at 495 nm using the PHERAstar microplate reader (BMG) and applied to determine IC50 values with the Origin 7.0 program.
体内活性: 在HEK293细胞中,MI-3与蛋白质靶点接近,进而对menin-MLL-AF9相互作用产生明显的抑制效果。在携带不同MLL易位的人MLL白血病细胞系中,MI-3有效阻断细胞分化并促使细胞凋亡。通过对MLL融合蛋白致癌活性所的靶点基因表达的下调,MI-3对MLL融合蛋白介导的白血病转化产生有效阻断作用。
存储条件: store at low temperature,keep away from direct sunlightPowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : 16 mg/mL (42.6 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 16 mg/mL (42.6 mM)
关键字: Apoptosis | MI3 | MI-3 | inhibit | Epigenetic Reader Domain | Inhibitor
相关产品: Soyasapogenol B | GSK1904529A | 9-ING-41 | SFI003 | Monastrol | 3,4-Dicaffeoylquinic acid | SU11274 | Etretinate | rac-CCT-250863 HCl | anti-TNBC agent-2
相关库: Bioactive Compounds Library Max | Inhibitor Library | Epigenetics Compound Library | Apoptosis Compound Library | PPI Inhibitor Library | NO PAINS Compound Library | Histone Modification Compound Library | Chromatin Modification Compound Library | Bioactive Compound Library
化合物MI-3 T2643信息由TargetMol中国为您提供,如您想了解更多关于化合物MI-3 T2643报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途